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your recommendation of a new threshold of 3.5 cm, which, if I
understood well, is based on the observation of a cohort of patients
where you operated on patients who reached the 2.5 threshold.
And, this doesn’t make a lot of sense to me, because I would rather
make this recommendation after following a cohort of patients
where surgery was delayed at the 3.5 threshold and no complica-
tions were observed.
Dr Gustavo Oderich. The average diameter in the cohort
who underwent observation was 3 cm, and after a mean follow-
up of 49 months, there were no complications among patients
with aneurysms <3.5 cm. Yes, we have not followed patients indef-
initely and 61 of 114 patients were repaired for “growth” or size
>2.5 cm, with average size of 2.9 cm in this subset of patients. If
we look at the 12 patients that had an acute event, the average
size was 5 cm; and in fact, there was one patient with a 3.5-cm aneu-
rysm, and the others had aneurysms signiﬁcantly larger than 4 cm.
So, the best recommendations we can make based on this
retrospective review are that there were no complications for aneu-
rysms <3.5 cm, and therefore this size can be considered as a new
threshold for repair. I do agree the study has limitations due to the
design and lack of predeﬁned protocol, but it does show that
complications have not occurred in smaller aneurysms, and most
certainly there is little evidence that repair is really needed earlier
for smaller aneurysms.
Dr Carmo. My second question is: would you recommend
a lower threshold for patients with a particularly active life, for
example, riding a bike or gardening, where hip movements can
have some impact?
Dr Oderich. This study also shows that even in a multicenter
experience, the repair can be done safely with very low mortality
and morbidity. So, it’s difﬁcult to argue not to repair a patient
that is young, healthy, and has a very active lifestyle as you out-
lined. Our data have shown that age <60 years old was indepen-
dently associated with higher rates of aneurysm complications. I
do think that it is reasonable to repair the aneurysm at a smaller
size, larger than 2.5 cm, in a younger patient, particularly if there
is growth or any concern due to thrombus.
Dr Kamran Karimi (Cedar Falls, Iowa). Would your
threshold of repair be different in a common femoral artery aneu-
rysm if the superﬁcial femoral artery is occluded?
Dr Oderich. Good question. We analyzed the threshold as
a group. But, evidently as we move distal on the circulation, that
may not necessarily apply. The few superﬁcial femoral artery aneu-
rysms included in this study were in the very proximal, encroachingthe common femoral artery. For distal superior femoral artery
aneurysms, we use the same recommendations as for popliteal
aneurysms.
Dr George Hamilton (London, United Kingdom). You’ve
got potentially two groups here. I just wonder whether you
analyzed for the effect of best medical therapy and particularly
the use of statins. Did you ﬁnd a difference between the two? In
other words, the groups that you didn’t operate on that didn’t
expand and the group that did.
Dr Oderich. Well, the credit really goes to Dr Lawrence. He
has a number of other ongoing projects, and I would welcome the
membership to contact him if interested in collaborating.
Dr Hamilton. The question was really about the use of statins
and best medical therapy, not endovascular therapy.
Dr Oderich. To answer your question, we have no informa-
tion on medical therapy.
Dr George Meier (Cincinnati, Ohio). Gustavo, I noticed that
your length of stay was 7 days on average. Was that due to outliers,
or were they really in the hospital that long? It seems longer than I
would expect.
Dr Oderich. I agree. One limitation of the data set is that
there is a number of patients who had concomitant aortic repair,
explaining the longer length of stay. And, perhaps Dr Lawrence
can comment on that, but that is a limitation of the data set and
I don’t have the information on the details of that.
Dr Peter Lawrence (Los Angeles, Calif). This database
approach provides a very large data set, but there are some limita-
tions to analysis. The prolonged length of stay reasons are unique
to each institution, but they are skewed by the emergent femoral
aneurysms with thrombolysis and amputation. Also this is
a 10-year study, so the data go back to an era when length of
stay was not such a big issue. I believe that length of stay would
be much shorter if the data were collected in 2013, particularly
for those patients who had an elective femoral aneurysm repair.
Dr Rombout Kruse (Zwolle, The Netherlands). Very inter-
esting to see these diseases being treated in your presentation
that are so rare. I have a question about the groin infections. If I
have it correct, you saw 12% groin infections. Did you use in
your study only Dacron, or did you also use venous interposition
or other materials?
Dr Oderich. The rate of 12 complications actually includes
a combination of all wound-related complications and that consists
of seromas, lymphatic leaks, and infections. The most common
conduit used is polyester graft. Vein has not been used to replace
at least in a larger number of patients.
